EUR
4,75 RON
(-0.07%)
USD
4,19 RON
(+0.15%)
GBP
5,42 RON
(-0.12%)
CHF
4,18 RON
(-0.11%)
AUD
3,00 RON
(+0.06%)
CAD
3,17 RON
(+0.05%)
BGN
2,43 RON
(-0.14%)
RUB
0,06 RON
(+0.05%)
ZAR
0,30 RON
(+0.53%)
BRL
1,12 RON
(+0.94%)
CNY
0,62 RON
(+0.05%)
INR
0,06 RON
(+0.25%)

Salariaţii „Antibiotice” nu pot achiziţiona acţiuni la un preţ preferenţial

0
Preşedintele AVAS, domnul Răzvan Orăşanu, s-a întâlnit cu liderii Federaţiei Sindicatelor Libere din Chimie-Petrochimie, la care sunt afiliaţi şi salariaţii societăţii „Antibiotice”  SA Iaşi. Liderii sindicali au solicitat preşedintelui Autorităţii să le faciliteze vânzarea, în condiţii preferenţiale, respectiv la valoarea nominală, a unui pachet de 10% din acţiunile companiei. Sindicatele îşi motivează demersul cu rezultatele foarte bune obţinute de companie ca urmare a activităţii pe care au desfăşurat-o.
Preşedintele AVAS consideră că nu poate da curs solicitării salariaţilor, pentru că astfel ar fi diminuat pachetul majoritar deţinut de stat, de 53,027%.
The decision of AVAS President Răzvan Orăşanu is based on the following reasons:
¤ The state-owned share package would be reduced to below 51%, which would significantly diminish the interest of potential investors who want a controlling package;
¤ Selling a reduced stock of shares would mean reducing the additional amount of value that the state will be able to obtain;
¤ The employees could receive a bonus from the new shareholder, who will have his own motivation strategy for the employees.
¤ The interest shown by potential investors is for a controlling package of 60-70% of shares. AVAS owns 53.027% of the share capital of „Antibiotice”. In order to make the most of the state-owned shares, AVAS initiated discussions with minority shareholders for the sale of a controlling stake in a joint offer.

The privatization strategy of „Antibiotice”, which President Răzvan Orăşanu will submit to the Executive’s attention, stipulates the following steps:
1. Publication of the privatization announcement in the first part of November;
From the moment of the publication of the privatization offer, potential investors will have a one month window during which they can submit pre-qualification documents to:
– Demonstrate the experience they have in the pharmaceutical industry and the ability to do financial investments (for investment funds);
– have the capacity to achieve development investments, working capital and environmental protection (amounts to be published in the sales notice).
2. selection based on pre-qualification criteria;
Competitors will be selected by applying the prequalification criteria listed in the ad. Selected companies will be invited to submit their financial offers in the second part of December.
3. the short list;
On the basis of the financial offer submitted by the potential bidders, AVAS will select the first two.
4. the winner’s designation;
By the end of December, the first two bidders remaining in the privatization race will submit improved and final bids based on which the winner will be selected. The terms of the privatization contract will be negotiated as of January 2007.
loading...

Citește și

Spune ce crezi

Adresa de email nu va fi publicata

Acest sit folosește Akismet pentru a reduce spamul. Află cum sunt procesate datele comentariilor tale.